Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q38460223)
Watch
English
Programmed cell death-1 inhibition in lymphoma.
scientific article published on May 2015
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
review article
1 reference
stated in
Europe PubMed Central
title
Programmed cell death-1 inhibition in lymphoma
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
main subject
cell death
1 reference
based on heuristic
inferred from title
author
Eliza A Hawkes
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
author name string
Andrew Grigg
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
Geoff Chong
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
publication date
1 May 2015
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
volume
16
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
issue
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
page(s)
e234-45
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
cites work
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel therapy for Hodgkin lymphoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibitory B7-family molecules in the tumour microenvironment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The blockade of immune checkpoints in cancer immunotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-1 and its ligands in tolerance and immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnostic and prognostic utility of PD-1 in B cell lymphomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RNA fingerprints provide direct evidence for the inhibitory role of TGF and PD-1 on CD4+ T cells in Hodgkin lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic significance of programmed cell death-1-positive cells in follicular lymphoma patients may alter in the rituximab era.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The microenvironment in follicular lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nivolumab plus ipilimumab in advanced melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970103-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(15)70103-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
PubMed publication ID
25943068
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25943068
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943068%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit